EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic and Functional Characterization of STAT4 in Rheumatoid Arthritis Patients with Distinct Disease Activity

Karla Mayela Bravo-Villagra, Rocio Guadalupe Hernández-Ruíz iD, Alejandra Landeros-Sáenz, Christian Johana Baños-Hernández iD, Sergio Cerpa-Cruz, Samuel García-Arellano iD, José Francisco Muñoz-Valle iD, Andres López-Quintero iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262010011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Karla Mayela Bravo-Villagra und 7 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Nutrigenética y Nutrigenómica Traslacional, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guad…. Hauptthemen laut MEDLINE: STAT4 Transcription Factor, Arthritis, Rheumatoid. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coecytjal. Scientific Development Fund of Jalisco to Address Social Challenges "FODECIJAL 2023.", Call for Proposals of the Scientific Development Fund of Jalisco to Address Social Challenges, Secretariat of Science, Humanities, Technology and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatoid arthritis (RA) is characterized by chronic inflammation mediated by the JAK/STAT pathway. Variants in STAT4 have been associated with autoimmune susceptibility, but their functional role in RA remains unclear. The aim of this study was to genetically and functionally characterize STAT4 in RA patients with varying disease activity by analyzing two variants, mRNA expression, phosphorylated STAT4 (pSTAT4), and inflammatory cytokines (IL-12, IL-23, and IFN-γ). Sixty-three Mexican patients with RA were stratified into remission/low and moderate/high activity groups. Genotyping, STAT4 mRNA expression, pSTAT4 quantification, cytokine profiling, and treatment analyses were conducted. Patients receiving methotrexate, hydroxychloroquine, and sulfasalazine had higher IL-12 concentrations compared with those on other regimens. In remission/low activity patients, GC/GC carriers exhibited increased IL-12, PBMC levels, and anti-CCP antibodies, while GC/TT carriers in the moderate/high activity group showed distinct ESR values. Secondary analyses revealed that TT/TT carriers with STAT4 overexpression exhibited higher IFN-γ and IL-23 levels. IL-12 differences persisted among GC/GC carriers regardless of STAT4 expression status. In conclusion, these exploratory findings suggest potential interactions among STAT4 haplotypes, expression status, and treatment regimens influencing cytokine and inflammatory profiles in RA. However, due to the small subgroup sizes, the observed associations should be interpreted with caution and considered hypothesis-generating until validated in larger cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT4 Transcription FactorArthritis, RheumatoidHumansMaleFemaleMiddle AgedAdultCytokinesPolymorphism, Single NucleotideGenotypeGenetic Predisposition to DiseaseAgedAntirheumatic AgentsHaplotypesInterferon-gammaInterleukin-12

Stichwörter der Autor:innen

IFN-γIL-12IL-23STAT4mRNApSTAT4rheumatoid arthritisrs11889341rs7574865

Substanzen

STAT4 Transcription FactorSTAT4 protein, humanCytokinesAntirheumatic AgentsInterferon-gammaInterleukin-12

Autor:innen und Institutionen

  • Instituto de Nutrigenética y Nutrigenómica Traslacional, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Mexico.
  • Programa de Doctorado en Genética Humana, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Mexico.
  • Programa de Doctorado en Ciencias de la Nutrición Traslacional, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Mexico.
  • Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara 44200, Mexico.
  • Instituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (UdeG), Guadalajara 44340, Mexico.

ORCID-Profile: Rocio Guadalupe Hernández-Ruíz, Christian Johana Baños-Hernández, Samuel García-Arellano, José Francisco Muñoz-Valle, Andres López-Quintero

Förderung

  • Coecytjal. Scientific Development Fund of Jalisco to Address Social Challenges "FODECIJAL 2023."
  • Call for Proposals of the Scientific Development Fund of Jalisco to Address Social Challenges
  • Secretariat of Science, Humanities, Technology and Innovation

Zitieren

APA

Bravo-Villagra, K. M., Hernández-Ruíz, R. G., Landeros-Sáenz, A., Baños-Hernández, C. J., Cerpa-Cruz, S., García-Arellano, S., Muñoz-Valle, J. F., & López-Quintero, A. (2025). Genetic and Functional Characterization of STAT4 in Rheumatoid Arthritis Patients with Distinct Disease Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010011

Vancouver

Bravo-Villagra KM, Hernández-Ruíz RG, Landeros-Sáenz A, Baños-Hernández CJ, Cerpa-Cruz S, García-Arellano S, et al. Genetic and Functional Characterization of STAT4 in Rheumatoid Arthritis Patients with Distinct Disease Activity. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010011

BibTeX
@article{BravoVillagra2025,
  author = {Bravo-Villagra, Karla Mayela and Hernández-Ruíz, Rocio Guadalupe and Landeros-Sáenz, Alejandra and Baños-Hernández, Christian Johana and Cerpa-Cruz, Sergio and García-Arellano, Samuel and Muñoz-Valle, José Francisco and López-Quintero, Andres},
  title = {Genetic and Functional Characterization of STAT4 in Rheumatoid Arthritis Patients with Distinct Disease Activity},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262010011}
}
Kostenlos starten →